Showing results (2531-2540 of 2,892) with videos related to

Sort By:
Pageof 290
BJOG : an International Journal of Obstetrics and Gynaecology|May 23, 2007
The Control of Hypertension In Pregnancy Study pilot trialL A Magee, P von Dadelszen, S Chan, et al.
Antiviral Research|May 24, 2011
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661Phillip A Furman, Eisuke Murakami, Congrong Niu, et al.
Pediatric Nephrology (Berlin, Germany)|September 27, 2015
Rare variants in tenascin genes in a cohort of children with primary vesicoureteric refluxShan Elahi, Alison Homstad, Himani Vaidya, et al.
The Annals of Thoracic Surgery|December 12, 2003
A multicenter comparison of intraaortic balloon pump utilization in isolated coronary artery bypass graft surgeryRoger J F Baskett, Gerald T O'Connor, Gregory M Hirsch, et al.
International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2018
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerE S Sokol, Y X Feng, D X Jin, et al.
Cancer Discovery|July 28, 2019
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLCPablo E Hollstein, Lillian J Eichner, Sonja N Brun, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibitionDavid A Fabrizio, Thomas J George, Richard F Dunne, et al.
BMC Cardiovascular Disorders|September 17, 2024
Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networksYuan Lu, Ellen C Keeley, Eric Barrette, et al.
Journal of Clinical Epidemiology|June 28, 2023
Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping reviewAnthony Muchai Manyara, Philippa Davies, Derek Stewart, et al.
Pageof 290